Amalgamated Bank Apellis Pharmaceuticals, Inc. Transaction History

Amalgamated Bank

  • $12.1 Billion
  • Q3 2024

A detailed history of Amalgamated Bank transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 6,995 shares of APLS stock, worth $231,814. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,995
Previous 6,995 -0.0%
Holding current value
$231,814
Previous $268,000 24.63%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024
BUY
$38.07 - $59.71 $13,667 - $21,435
359 Added 5.41%
6,995 $268,000
Q1 2024

Apr 23, 2024
SELL
$55.39 - $72.47 $765,545 - $1 Million
-13,821 Reduced 67.56%
6,636 $390,000
Q4 2023

Feb 06, 2024
SELL
$37.14 - $64.82 $64,177 - $112,008
-1,728 Reduced 7.79%
20,457 $1.23 Million
Q3 2023

Nov 08, 2023
BUY
$23.65 - $89.22 $18,044 - $68,074
763 Added 3.56%
22,185 $844,000
Q2 2023

Aug 11, 2023
BUY
$76.68 - $93.31 $623,255 - $758,423
8,128 Added 61.14%
21,422 $1.95 Million
Q1 2023

May 02, 2023
SELL
$46.59 - $66.96 $98,258 - $141,218
-2,109 Reduced 13.69%
13,294 $877,000
Q4 2022

Feb 10, 2023
BUY
$43.24 - $61.04 $9,988 - $14,100
231 Added 1.52%
15,403 $796,000
Q3 2022

Nov 09, 2022
BUY
$44.76 - $69.66 $34,554 - $53,777
772 Added 5.36%
15,172 $1.04 Million
Q2 2022

Aug 15, 2022
BUY
$35.07 - $59.21 $67,895 - $114,630
1,936 Added 15.53%
14,400 $651,000
Q1 2022

Jun 30, 2022
SELL
$35.46 - $54.12 $3,085 - $4,708
-87 Reduced 0.69%
12,464 $633,000
Q4 2021

Feb 15, 2022
BUY
$30.74 - $49.16 $30,647 - $49,012
997 Added 8.63%
12,551 $593,000
Q3 2021

Oct 29, 2021
SELL
$31.4 - $69.84 $22,325 - $49,656
-711 Reduced 5.8%
11,554 $381,000
Q2 2021

Aug 16, 2021
BUY
$40.9 - $64.9 $151,943 - $241,103
3,715 Added 43.45%
12,265 $775,000
Q1 2021

May 13, 2021
SELL
$40.8 - $57.39 $33,986 - $47,805
-833 Reduced 8.88%
8,550 $367,000
Q4 2020

Feb 12, 2021
BUY
$30.79 - $57.2 $1,570 - $2,917
51 Added 0.55%
9,383 $536,000
Q3 2020

Oct 30, 2020
SELL
$25.89 - $33.65 $7,300 - $9,489
-282 Reduced 2.93%
9,332 $282,000
Q2 2020

Aug 10, 2020
BUY
$24.8 - $38.49 $3,149 - $4,888
127 Added 1.34%
9,614 $314,000
Q1 2020

May 13, 2020
BUY
$17.91 - $44.33 $13,396 - $33,158
748 Added 8.56%
9,487 $254,000
Q4 2019

Feb 13, 2020
BUY
$22.1 - $30.8 $3,580 - $4,989
162 Added 1.89%
8,739 $268,000
Q3 2019

Nov 13, 2019
SELL
$24.09 - $32.18 $1,927 - $2,574
-80 Reduced 0.92%
8,577 $207,000
Q2 2019

Aug 14, 2019
BUY
$18.0 - $25.34 $155,826 - $219,368
8,657 New
8,657 $219,000

Others Institutions Holding APLS

# of Institutions
308
Shares Held
115M
Call Options Held
3.85M
Put Options Held
1.09M
View Full List

About Apellis Pharmaceuticals, Inc.

APLS Quotes by TradingView
  • Ticker APLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 109,865,000
  • Market Cap $3.64B
  • Description
  • Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...
More about APLS
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email